Academic Journal

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis

التفاصيل البيبلوغرافية
العنوان: Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis
المؤلفون: Chegou, Novel N., Sutherland, Jayne S., Namuganga, Anna-Ritah, Corstjens, Paul LAM, Geluk, Annemieke, Gebremichael, Gebremedhin, Mendy, Joseph, Malherbe, Stephanus, Stanley, Kim, van der Spuy, Gian D., Kriel, Magdalena, Loxton, Andre G., Kriel, Belinda, Simukonda, Felanji, Bekele, Yonas, Sheehama, Jacob A., Nelongo, Josefina, van der Vyver, Marieta, Gebrexabher, Atsbeha, Hailu, Habteyes, Esterhuyse, Maria M., Rosenkrands, Ida, Aagard, Claus, Kidd, Martin, Kassa, Desta, Mihret, Adane, Howe, Rawleigh, Cliff, Jacqueline M., Crampin, Amelia C., Mayanja-Kizza, Harriet, Kaufmann, Stefan H. E., Dockrell, Hazel M., Ottenhoff, Tom H. M., Walzl, Gerhard, McAnda, Shirley P., Owolabi, Olumuyiwa, Sillah, Abdou, Gindeh, Awa, Donkor, Simon, Togun, Toyin, Ota, Martin, Muzanye, Grace, Nsereko, Mary, Peters, Pierre, Tjon Kon Fat, Elisa M., de Dood, Claudia J., Franken, Kees, van der Ploeg-van Schip, Jolien J., Gebrezgeabher, Atsbeha, Mesfin, Getnet
المصدر: Scientific Reports ; volume 8, issue 1 ; ISSN 2045-2322
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2018
الوصف: We investigated host-derived biomarkers that were previously identified in QuantiFERON supernatants, in a large pan-African study. We recruited individuals presenting with symptoms of pulmonary TB at seven peripheral healthcare facilities in six African countries, prior to assessment for TB disease. We then evaluated the concentrations of 12 biomarkers in stored QuantiFERON supernatants using the Luminex platform. Based on laboratory, clinical and radiological findings and a pre-established algorithm, participants were classified as TB disease or other respiratory diseases(ORD). Of the 514 individuals included in the study, 179(34.8%) had TB disease, 274(51.5%) had ORD and 61(11.5%) had an uncertain diagnosis. A biosignature comprising unstimulated IFN-γ, MIP-1β, TGF-α and antigen-specific levels of TGF-α and VEGF, identified on a training sample set (n = 311), validated by diagnosing TB disease in the test set (n = 134) with an AUC of 0.81(95% CI, 0.76–0.86), corresponding to a sensitivity of 64.2%(95% CI, 49.7–76.5%) and specificity of 82.7%(95% CI, 72.4–89.9%). Host biomarkers detected in QuantiFERON supernatants can contribute to the diagnosis of active TB disease amongst people presenting with symptoms requiring investigation for TB disease, regardless of HIV status or ethnicity in Africa.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41598-018-20855-7
الاتاحة: http://dx.doi.org/10.1038/s41598-018-20855-7
https://www.nature.com/articles/s41598-018-20855-7
https://www.nature.com/articles/s41598-018-20855-7.pdf
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.276F00B6
قاعدة البيانات: BASE
الوصف
DOI:10.1038/s41598-018-20855-7